The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease
Abstract
BACKGROUND: Bowen's disease (BD; intraepithelial squamous cell carcinoma) is therapeutically challenging because lesions, which may be multiple, are frequently located at sites that heal poorly. There is a small risk of progression to invasive carcinoma. Photodynamic therapy (PDT) is an effective treatment for certain non melanoma skin cancers, but comparison studies with other, better-established therapies are limited. OBJECTIVES: To compare the efficacy and tolerability of PDT and topical 5-fluorouracil (5-FU) in BD. METHODS: Forty patients from two centres were randomized to either topical PDT or 5-FU. The PDT group was treated with 20% 5-aminolaevulinic acid (ALA) applied 4 h before illumination with 100 J cm-2 narrowband red light (630 +/- 15 nm). 5-FU was applied to lesions for 4 weeks. A repeat treatment cycle was performed after 6 weeks if required. Results Twenty-nine of 33 (88%) lesions treated with PDT initially responded completely, compared with 22 of 33 (67%) after 5-FU. After 12 months, two recurrences in the PDT group and six in the 5-FU group reduced complete clinical clearance rates to 82% and 48%, respectively. PDT was significantly more effective (P = 0.006, odds ratio 4.78, 95% confidence interval 1.56-14.62). In the 5-FU group, severe eczematous reactions developed around seven lesions, ulceration in three and erosions in two. No such reactions occurred following PDT. There was no difference in overall pain experienced during each therapy. CONCLUSIONS: Topical ALA-PDT is more effective than topical 5-FU in the treatment of BD, with fewer adverse events. ALA-PDT should be considered one of the first-line therapeutic options for BD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HOW DOES PHOTODYNAMIC THERAPY WORK?
Henderson, B. W., & Dougherty, T. J. (1992) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1992.tb04222.x · Cited by 2,358
THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES
Cohen, S. S., Flaks, J. G., Barner, H. D., Loeb, M. R., & Lichtenstein, J. (1958) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.44.10.1004 · Cited by 639
Photodynamic therapy in dermatology
Kalka, K., Merk, H., & Mukhtar, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90209-3 · Cited by 522
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease
MORTON, C. A., WHITEHURST, C., MOSELEY, H., MCCOLL, J. H., MOORE, J. V., & MACKIE, R. M. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1076.x · Cited by 306
Self-citationTopical chemotherapy with 5-fluorouracil
Goette, D. K. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)80196-x · Cited by 227
Kurwa, H. A., Yong-Gee, S. A., Seed, P. T., Markey, A. C., & Barlow, R. J. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70114-3 · Cited by 198
Guidelines for management of Bowen's disease
Cox, Eedy, & Morton (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03100.x · Cited by 190
Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton, C. A., Whitehurst, C., McColl, J. H., Moore, J. V., & Mackie, R. M. (2001) · PubMed · Cited by 190
Self-citationRud, E., Gederaas, O., Høgset, A., & Berg, K. (2007) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0710640aabnaa2.0.co2 · Cited by 171
Morton, C. A., Whitehurst, C., Moore, J. V., & Mackie, R. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03773.x · Cited by 158
Self-citation
Cited by
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
The present and future role of photodynamic therapy in cancer treatment
Brown, S. B., Brown, E. A., & Walker, I. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01529-3 · Cited by 1,771
Braathen, L. R., Szeimies, R.-M., Basset-Seguin, N., Bissonnette, R., Foley, P., Pariser, D., Roelandts, R., Wennberg, A.-M., & Morton, C. A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.006 · Cited by 662
Self-citationGuidelines for topical photodynamic therapy: update
Morton, C. A., McKenna, K. E., Rhodes, L. E., & on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08882.x · Cited by 471
Self-citationCutaneous Squamous Cell Carcinoma
Waldman, A., & Schmults, C. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.08.001 · Cited by 424
Metadata
- Authors
- Salim, A., Leman, J. A., McColl, J. H., Chapman, R., & Morton, C. A.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-03
- Volume
- 148
- Issue
- 3
- Pages
- 539-543
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2000537570
- Cited by
- 254
- References
- 14
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. https://app.cochat.ai/papers/10.1046/j.1365-2133.2003.05033.x
- The paper
- Salim, A., Leman, J. A., McColl, J. H., Chapman, R., & Morton, C. A. (2003). Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. British Journal of Dermatology. https://doi.org/10.1046/j.1365-2133.2003.05033.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.